U-Blot® Research Grade Anti-HIV1 gp120/Glycoprotein 120 Antibody (mD1.22)Cat. No. WA1132Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-HIV1 gp120/Glycoprotein 120 Antibody (mD1.22)Cat. No. WA1132
U-Blot® Research Grade Anti-HIV1 gp120/Glycoprotein 120 Antibody (m36.4)Cat. No. WA1131
U-Blot® Research Grade Anti-HIV1 gp120/Glycoprotein 120 (VRC01LS)Cat. No. WA1130
U-Blot® Research Grade Anti-HIV-1 gp120/Glycoprotein 120 (N6LS)Cat. No. WA1129
U-Blot® Research Grade Anti-HIV1 gp120/Glycoprotein 120 & CD4 Antibody (GS-8588)Cat. No. WA1128
U-Blot® Research Grade Anti-HIV gp120SU (VRC01)Cat. No. WA1127
U-Blot® Research Grade Anti-HCV NS1/Envelope glycoprotein E2 (MBL-HCV1)Cat. No. WA1126
U-Blot® Research Grade Anti-HCV NS1/Envelope glycoprotein E2 (HuMax-HepC)Cat. No. WA1125
U-Blot® Research Grade Anti-HBV HBsAg Antibody (VIR-3434)Cat. No. WA1124
U-Blot® Research Grade Anti-HBsAg Reference Antibody (OST 577)Cat. No. WA1123
U-Blot® Research Grade Anti-Ganglioside GD3 (PF-06688992)Cat. No. WA1122
U-Blot® Research Grade Anti-Ganglioside GD2 (ATL301)Cat. No. WA1121